Free Trial
ASX:BKL

Blackmores (BKL) Stock Price, News & Analysis

Blackmores logo

About Blackmores Stock (ASX:BKL)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
75,759 shs
Average Volume
N/A
Market Capitalization
$1.84 billion
P/E Ratio
59.98
Dividend Yield
1.84%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health. In addition, the company offers products in the areas of fish and nutritional oils; heart and circulation; infant nutrition; kids health; men's health; multivitamins; nails, hair, and skin; pet health; probiotics; pregnancy and preconception; stress relief and sleep support; weight management; wellbeing management; and women's health. It provides its products through retail and online channels. The company was founded in 1930 and is headquartered in Sydney, Australia.

Remove Ads
Receive BKL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Blackmores and its competitors with MarketBeat's FREE daily newsletter.

BKL Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Clover Corp Ltd UWA
See More Headlines

BKL Stock Analysis - Frequently Asked Questions

Blackmores Limited (ASX:BKL) issued its quarterly earnings results on Tuesday, February, 19th. The company reported $1.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.18 by $0.19. Blackmores had a trailing twelve-month return on equity of 7.96% and a net margin of 4.71%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Blackmores investors own include Citizens (CIA), Bonavista Energy Co. (BNP.TO) (BNP), Altium (ALU), OncoSil Medical (OSL), Pinnacle West Capital (PNW), Select Harvests (SHV) and ECN Capital (ECN).

Company Calendar

Last Earnings
2/19/2019
Today
4/02/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Packaged Foods
Sub-Industry
N/A
Current Symbol
ASX:BKL
CIK
N/A
Fax
N/A
Employees
1,200
Year Founded
N/A

Profitability

Trailing P/E Ratio
59.98
Forward P/E Ratio
N/A
P/E Growth
1.31
Net Income
$34.61 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$645 million
Price / Cash Flow
39.12
Book Value
A$21.08 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.84 billion
Optionable
Not Optionable
Beta
0.61
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (ASX:BKL) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners